# GC녹십자웰빙 breaks ground on medical device GMP plant in Eumseong, South Korea

GC녹십자웰빙 held a groundbreaking ceremony on November 2, 2026 for a new medical device GMP plant in Eumseong, Chungcheongbuk-do, South Korea. The facility will produce fillers and skin boosters with an annual capacity of up to 3 million units, with completion targeted for Q2 2027.

- Type: New facility
- Announced: 2026-11-02
- Where: Eumseong, Chungcheongbuk-do, South Korea
- Starts operating: Q2 2027
- Status: under construction
- Capacity: 3 million units per year
- Products: fillers, skin boosters
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GC녹십자웰빙](https://endata.com/companies/94825.md)

## Sources

- [nanumy.co.kr](https://www.nanumy.co.kr/news/articleView.html?idxno=4011327), 2026-11-04: "이번 착공은 단순한 생산시설 확충을 넘어 메디컬 에스테틱 사업의 지속적인 성장을 위한 중요한 출발점"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.